Femme Homme
- | Pays :
- Georgia
- Russian Federation
- Ukraine
- | Organes : -
- | Spécialités : -
Extrait
This is a Phase I, multi-centre, open-label, cross-over pharmacokinetic study designed to investigate whether the co-administration of a fixed dose of tesmilifene alters the plasma pharmacokinetics of a standard regimen of epirubicin and/or its principle metabolite, epirubicinol and cyclophosphamide.
Critère d'inclusion
- Metastatic/Recurrent Breast Cancer